Fac­ing set­backs for months and an ac­tivist at­tack, Cat­a­lyst Bio­sciences pre­pares to call it quits

Af­ter down­siz­ing for sev­er­al months, Cat­a­lyst Bio­sciences is get­ting ready to tap out.

The San Fran­cis­co biotech an­nounced Wednes­day that it would be liq­ui­dat­ing and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER